VMP1-related autophagy induced by a fructose-rich diet in β-cells: its prevention by incretins

Clin Sci (Lond). 2017 Apr 25;131(8):673-687. doi: 10.1042/CS20170010. Epub 2017 Feb 10.

Abstract

The aim of the present study was to demonstrate the role of autophagy and incretins in the fructose-induced alteration of β-cell mass and function. Normal Wistar rats were fed (3 weeks) with a commercial diet without (C) or with 10% fructose in drinking water (F) alone or plus sitagliptin (CS and FS) or exendin-4 (CE and FE). Serum levels of metabolic/endocrine parameters, β-cell mass, morphology/ultrastructure and apoptosis, vacuole membrane protein 1 (VMP1) expression and glucose-stimulated insulin secretion (GSIS) were studied. Complementary to this, islets isolated from normal rats were cultured (3 days) without (C) or with F and F + exendin-4 or chloroquine. Expression of autophagy-related proteins [VMP1 and microtubule-associated protein light chain 3 (LC3)], apoptotic/antiapoptotic markers (caspase-3 and Bcl-2), GSIS and insulin mRNA levels were measured. F rats developed impaired glucose tolerance (IGT) and a significant increase in plasma triacylglycerols, thiobarbituric acid-reactive substances, insulin levels, homoeostasis model assessment (HOMA) for insulin resistance (HOMA-IR) and β-cell function (HOMA-β) indices. A significant reduction in β-cell mass was associated with an increased apoptotic rate and morphological/ultrastructural changes indicative of autophagic activity. All these changes were prevented by either sitagliptin or exendin-4. In cultured islets, F significantly enhanced insulin mRNA and GSIS, decreased Bcl-2 mRNA levels and increased caspase-3 expression. Chloroquine reduced these changes, suggesting the participation of autophagy in this process. Indeed, F induced the increase of both VMP1 expression and LC3-II, suggesting that VMP1-related autophagy is activated in injured β-cells. Exendin-4 prevented islet-cell damage and autophagy development. VMP1-related autophagy is a reactive process against F-induced islet dysfunction, being prevented by exendin-4 treatment. This knowledge could help in the use of autophagy as a potential target for preventing progression from IGT to type 2 diabetes mellitus.

Keywords: autophagy; fructose-induced β-cell injury; incretins; β-cell function; β-cell mass.

MeSH terms

  • Animals
  • Autophagy / drug effects*
  • Autophagy / physiology
  • Body Weight
  • Cells, Cultured
  • Diet / adverse effects*
  • Drug Evaluation, Preclinical / methods
  • Energy Intake
  • Exenatide
  • Fructose / administration & dosage
  • Fructose / pharmacology*
  • Glucose Intolerance / etiology
  • Glucose Intolerance / pathology
  • Glucose Intolerance / prevention & control
  • Glucose Tolerance Test
  • Hypoglycemic Agents / pharmacology
  • Incretins / pharmacology*
  • Insulin / biosynthesis
  • Insulin / genetics
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / ultrastructure
  • Male
  • Membrane Proteins / physiology*
  • Microscopy, Electron
  • Peptides / pharmacology
  • RNA, Messenger / genetics
  • Rats, Wistar
  • Sitagliptin Phosphate / pharmacology
  • Venoms / pharmacology

Substances

  • Hypoglycemic Agents
  • Incretins
  • Insulin
  • Membrane Proteins
  • Peptides
  • RNA, Messenger
  • VMP1 protein, rat
  • Venoms
  • Fructose
  • Exenatide
  • Sitagliptin Phosphate